GGrantIndex
Sort

48,018 grants matching immunotherapy

Fred Hutchinson Cancer Research Center Lung SPORE

$2,447,085
A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2023 · CA

Fred Hutchinson Cancer Research Center Lung SPORE

$2,447,059
A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2022 · CA

Nanosystems Biology Cancer Center

$2,446,594
James R. Heath · California Institute Of Technology · U54 · FY2016 · CA

Nanosystems Biology Cancer Center 2

$2,446,327
James R. Heath · California Institute Of Technology · U54 · FY2011 · CA

Hematopoiesis in cardiovascular disease

$2,446,169
Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2021 · HL

Durable Alteration of the Human Immune system after Infection or Immunotherapy

$2,446,152
Raymond T Chung · Massachusetts General Hospital · U19 · FY2024 · AI

Hematopoiesis in cardiovascular disease

$2,443,825
Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2022 · HL

Hematopoiesis in cardiovascular disease

$2,443,825
Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2023 · HL

Liver Cancer Program

$2,440,951
Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

MEMORIAL SLOAN-KETTERING CANCER GENE THERAPY PROGRAM

$2,439,650
Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA

Mayo Clinic Breast Cancer SPORE

$2,438,534
Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2017 · CA

SPORE: Targeted Therapies for Glioma

$2,438,174
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2019 · CA

Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models

$2,438,130
Einar M Sigurdsson · New York University School Of Medicine · RF1 · FY2021 · NS

Case Clinical Trials Unit

$2,436,364
Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2023 · AI

Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers

$2,436,054
Paul M. Lieberman · Wistar Institute · P01 · FY2023 · CA

Simian Vaccine Evaluation Units

$2,435,221
Mark Lewis · Bioqual, Inc. · N01 · FY2012 · AI

The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer

$2,434,565
Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA

COG NCTN Year 10 BIQSFP Supplement & Progress Report

$2,432,383
Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA

Role of microbiome in cancer and inflammation

$2,431,118
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Megabase Scale Genome Engineering and Synthesis in Mammalian Cells

$2,431,000
Kaihang Wang · California Institute Of Technology · DP2 · FY2020 · GM

Mechanisms Underlying Clearance of Persistent Infections

$2,430,939
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

MANAGEMENT OF CANCER WITH MONOCLONAL ANTIBODIES

$2,430,562
Ctr For Molecular Medicine/Immunology · P01 · FY2000 · CA

Molecular mechanism of natural killer cell recognition

$2,430,000
Jun Huang · University Of Chicago · DP2 · FY2018 · AI

Human anti-viral immune responses in tissues and circulation

$2,429,067
Donna L Farber · Columbia University Health Sciences · U19 · FY2018 · AI

Case Clinical Trials Unit

$2,428,514
George Yendewa · Case Western Reserve University · UM1 · FY2025 · AI